Blog

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  

Blog
Dec 24, 2024, 18:16 | Blog
Ronit Satchi-Fainaro: Target Therapies in P-selectin-expressing cancers
Ronit Satchi-Fainaro, Visiting Full Professor at University of Lisbon, shared a post on LinkedIn: “Thrilled…
Dec 24, 2024, 18:11 | Blog
Bishal Gyawali: Are U.S. patients paying twice for cancer drugs?
Bishal Gyawali, Associate Professor at Queen’s University, shared on X: “Are U.S. patients paying twice…
Dec 24, 2024, 18:09 | Blog
Megan-Claire Chase: Navigating cancer as a single person diagnosed under 40
Megan-Claire Chase, Breast Cancer Program Director for SHARE Cancer Support, shared on LinkedIn: “Here’s one…
Dec 24, 2024, 18:06 | Blog
Elvina Almuradova: ESPAC4 Long-Term Results in Journal of Clinical Oncology
Elvina Almuradova, Associate Professor at Medicana Health Group, shared a post on LinkedIn: “ESPAC4 Long-Term…
Dec 24, 2024, 18:03 | Blog
Andrea Lancia: Excited to participate in the next GU Oncology Early Career Thought Leaders Conference!
Andrea Lancia, Associate Editor of Frontiers in Oncology, shared on LinkedIn: “Excited to participate in…
Dec 24, 2024, 17:55 | Blog
Layth Mula-Hussain: Prognostic factors and survival in patients with NSCLC and brain metastases
Layth Mula-Hussain, Radiation Oncologist and Assistant Professor at Dalhousie University, shared on LinkedIn: “Recently released.…
Dec 24, 2024, 17:41 | Blog
Mahipal Singh Bhanot: From Fear to Faith - Fortis Gurugram’s Legacy in Hematology
Mahipal Singh Bhanot, Senior Vice President and Business Head shared on LinkedIn: "From Fear to…
Dec 24, 2024, 17:39 | Blog
Arif Kamal: Food is Medicine in Oncology Care Symposium
Arif Kamal shared on LinkedIn: "Growing up in Missouri, it wasn't unusual to have breakfast…
Dec 24, 2024, 17:32 | Blog
Three-Year Overall Survival with Nivolumab + Relatlimab rela-nivo in Advanced Melanoma
Marco Donia shared on LinkedIn: "Three-Year Overall Survival with Nivolumab + Relatlimab (rela-nivo) in Advanced…
Dec 24, 2024, 17:29 | Blog
VCU Massey Comprehensive Cancer Center - Current obstacles in achieving equitable care for patients with cancer
VCU Massey Comprehensive Cancer Center shared on X: "In March, Dr. Rob Winn spoke about…
All: 18869 Posts: 1 - 10
Special Coverage